Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Details)

v3.26.1
SEGMENT INFORMATION (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
SEGMENT INFORMATION    
Revenue $ 15,961 $ 13,139
Less: Segment expenses    
Research and development   39
Selling, general and administrative    
Stock compensation 989 1,323
Total operating expenses 17,453 16,463
Net Income (Loss) (2,230) (4,073)
Reconciliation to net loss:    
Net loss (2,230) (4,073)
Dermatological segment    
Selling, general and administrative    
Net Income (Loss) (2,230) (4,073)
Reconciliation to net loss:    
Net loss $ (2,230) $ (4,073)
Operating Segments    
Reconciliation to net loss:    
Segment Reporting, Other Segment Item, Composition, Description Other segment items for the reportable segment include amortization of intangible assets, interest income (expense), foreign exchange transaction losses and income tax expense. Other segment items for the reportable segment include amortization of intangible assets, interest income (expense), foreign exchange transaction losses and income tax expense.
Operating Segments | Dermatological segment    
SEGMENT INFORMATION    
Revenue $ 15,961 $ 13,139
Less: Segment expenses    
Cost of goods sold - (excluding amortization of acquired intangible assets) 6,218 4,790
Research and development   39
Selling, general and administrative    
Employee related 4,688 4,031
Sales, operations, outside services and consulting 2,162 3,078
Marketing related 944 1,057
Stock compensation 989 1,323
Legal and administrative 601 513
Product compliance expense 248 275
Office and administrative 279 226
Other 198 66
Other segment items 1,864 1,814
Total operating expenses 18,191 17,212
Net Income (Loss) (2,230) (4,073)
Reconciliation to net loss:    
Net loss $ (2,230) $ (4,073)